Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testolactone for Precocious Puberty in Girls
NCT00001181Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Oct 1982
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testolactone in precocious puberty, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Serum Estradiol Levels up to 5 years. Started Oct 1982; status: completed.
02
Drugs
testolactone
03
Conditions
precocious puberty
Beyond the preview
Go deeper on NCT00001181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001181.